| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 187.13B | 209.84B | 179.09B | 165.56B | 150.72B | 135.56B |
| Gross Profit | 41.46B | 47.05B | 38.71B | 34.40B | 30.29B | 28.49B |
| EBITDA | 15.13B | 16.73B | 13.55B | 12.35B | 10.60B | 9.86B |
| Net Income | 7.43B | 9.14B | 6.85B | 6.88B | 6.25B | 6.24B |
Balance Sheet | ||||||
| Total Assets | 192.33B | 220.29B | 196.78B | 168.84B | 142.69B | 133.06B |
| Cash, Cash Equivalents and Short-Term Investments | 72.81B | 27.27B | 36.28B | 14.88B | 11.72B | 21.29B |
| Total Debt | 40.91B | 39.61B | 40.42B | 27.01B | 14.40B | 12.41B |
| Total Liabilities | 110.02B | 126.14B | 111.43B | 93.17B | 76.05B | 73.51B |
| Stockholders Equity | 78.18B | 89.52B | 81.30B | 72.93B | 65.19B | 59.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.40B | 11.54B | -6.40B | -5.37B | 5.43B |
| Operating Cash Flow | 0.00 | 15.13B | 13.32B | -5.49B | -4.34B | 6.63B |
| Investing Cash Flow | 0.00 | -16.96B | -3.33B | -2.34B | -5.62B | -3.33B |
| Financing Cash Flow | 0.00 | -7.24B | 11.25B | 10.58B | -113.00M | -1.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥942.64B | 50.42 | 6.61% | 1.58% | -1.47% | -19.46% | |
75 Outperform | ¥231.89B | 14.59 | 9.02% | 3.11% | 9.57% | 40.16% | |
74 Outperform | ¥80.62B | 8.80 | 16.37% | 2.79% | 42.29% | 55.00% | |
73 Outperform | ¥739.27B | 22.03 | ― | 1.43% | 8.81% | 17.58% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥141.24B | 5.42 | 12.54% | 1.84% | 17.17% | 33.30% | |
59 Neutral | ¥223.48B | 15.21 | ― | 2.41% | 5.68% | -49.64% |